Integrating preventive cardiology in primary care: The role of nurses, pharmacists, health records, and emergency services

Badour Subhi Alaujan; Bander Ahmad Zamzami; Hind Amer Ababtain; Fatmah Malfi Altalouhi; Munifah Hamdan Alshammari; Eman Smair Alenizi; Ghuzyel Fahad Aldossary; Reem Sultan Alshaibani; Salwa Rashed Alowaidan; Albandary Falah Alharbi; Shayem Hamdan Alharbi; Fahad Madallah Alnuwmasiu; Fares Motalq Alonazi; Mohammed Nuhayr Alwahdani; Nasser Sihli Alshammary

doi:10.53730/ijhs.v5nS1.15060

Authors

Badour Subhi Alaujan KSA, National Guard Health Affairs
Bander Ahmad Zamzami KSA, National Guard Health Affairs
Hind Amer Ababtain KSA, National Guard Health Affairs
Fatmah Malfi Altalouhi ‏KSA, National Guard Health Affairs
Munifah Hamdan Alshammari ‏KSA, National Guard Health Affairs
Eman Smair Alenizi KSA, National Guard Health Affairs
Ghuzyel Fahad Aldossary ‏KSA, National Guard Health Affairs
Reem Sultan Alshaibani KSA, National Guard Health Affairs
Salwa Rashed Alowaidan ‏KSA, National Guard Health Affairs
Albandary Falah Alharbi KSA, National Guard Health Affairs
Shayem Hamdan Alharbi KSA, National Guard Health Affairs
Fahad Madallah Alnuwmasiu KSA, National Guard Health Affairs
Fares Motalq Alonazi KSA, National Guard Health Affairs
Mohammed Nuhayr Alwahdani KSA, National Guard Health Affairs
Nasser Sihli Alshammary KSA, National Guard Health Affairs

Keywords:

Integrating Preventive Cardiology, Primary Care, Nurses, Pharmacists, Health Records, Emergency Services, Review

Abstract

Background: Chronic metabolic and cardiovascular multi-comorbidities are increasing, with cardiovascular disease being the main cause of morbidity and mortality in type 2 diabetes patients. Traditional healthcare systems often lack a "main" specialist coordinating treatment, leading to fragmented care and higher costs. Advances in cardiometabolic pharmacology have blurred lines between specialties, emphasizing the need for a distinct cardiometabolic specialty. This interdisciplinary approach aims to optimize treatment, improve outcomes, and reduce medical expenditure. Aim of Work: The significant prevalence of cardiovascular disease and the concurrent obesity epidemic is exerting an exceptional pressure on the healthcare system. Under the present fragmented care paradigm, patients with cardiometabolic illness get only partial care from several experts, resulting in inadequate therapy, increased expenses, and worse results. Methods: A thorough and methodical search was conducted across several databases, including PubMed (including MEDLINE), CINAHL, EMBASE, and the Cochrane database for systematic reviews. Reference lists of included papers were also examined for relevant research. Results: There is an urgent need for a new treatment paradigm that involves establishing a separate specialty focused on cardiometabolic conditions, together with a dedicated outpatient clinic that provides complete care for these conditions.

Downloads

Download data is not yet available.

References

CDC. National Diabetes Statistics Report 2020. Estimates of diabetes and its burden in the United States 2020.

Fryar CD, Chen TC, Li X. Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010. NCHS Data Brief. 2012;2012:1–8.

Ferrannini G, De Bacquer D, De Backer G, Kotseva K, Mellbin L, Wood D, et al. Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery diseaseda persistent challenge in need of substantial improvement: a report from ESC EORP Euroaspire V. Diabetes Care. 2020;43(4):726–33. DOI: https://doi.org/10.2337/dc19-2165

Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: the Chicago Heart Association Detection Project in Industry study. Diabetes Care. 1997;20(2):163–9. DOI: https://doi.org/10.2337/diacare.20.2.163

Sidney S, Quesenberry CP, Jaffe MG, Sorel M, Nguyen-Huynh MN, Kushi LH, et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiol. 2016 Aug 1;1(5):594–9. DOI: https://doi.org/10.1001/jamacardio.2016.1326

McClellan M, Brown N, Califf RM, Warner JJ. Call to action: urgent challenges in cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. 2019 Feb 26 [cited 2020 Aug 10];139(9):E44–54. DOI: https://doi.org/10.1161/CIR.0000000000000652

2020 Heart Disease and Stroke Statistical Update Fact Sheet At-a-Glance Heart Disease, Stroke and other cardiovascular diseases. available from: https://www.heart.org/-/media/files/about-us/statistics/2020-heart-disease-and-stroke-ucm_505473.pdf?la=en. accessed 8.30.2020.

Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trendsinobesity and severe obesity prevalence in usyouth and adultsby sex and age, 2007–2008 to 2015–2016. JAMA - J Am Med Assoc. 2018 Apr 24 [cited 2020 Aug 11];319(16):1723–5. DOI: https://doi.org/10.1001/jama.2018.3060

Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440–50. DOI: https://doi.org/10.1056/NEJMsa1909301

Abdullah A, Wolfe R, Stoelwinder JU, de Courten M, Stevenson C, Walls HL, et al. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol. 2011;40(4):985–96. DOI: https://doi.org/10.1093/ije/dyr018

Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Vol. 139, Circulation. 2019. 56–528 p.

Guo F, Garvey, Timothy W. Trends in cardiovascular health metrics in obese adults: National Health and Nutrition Examination Survey (NHANES). [cited 2020 Mar 19];1988–2014.

Sarwar N, Gao P, Kondapally Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010 Jun 26 [cited 2020 Aug 11];375(9733):2215–22. DOI: https://doi.org/10.1016/S0140-6736(10)60484-9

Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017 Mar 7 [cited 2019 Sep 4];135(10). DOI: https://doi.org/10.1161/CIR.0000000000000491

Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J, et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J. 2000;21(16):1368–75. DOI: https://doi.org/10.1053/euhj.1999.2043

Fox CS, Larson MG, Leip EP, Culleton B, Wilson PWF, Levy D. Predictors of new-onset kidney disease in a community-based population. J Am Med Assoc. 2004;291(7):844–50. DOI: https://doi.org/10.1001/jama.291.7.844

Fox CS, Matsushita K, Woodward M, Bilo HJG, Chalmers J, Lambers Heerspink HJ, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;381(9864):374. DOI: https://doi.org/10.1016/S0140-6736(12)61350-6

Chu M, Wang AYM, Chan IHS, Chui SH, Lam CWK. Serum small-dense LDL abnormalities in chronic renal disease patients. Br J Biomed Sci. 2012;69(3):99–102. DOI: https://doi.org/10.1080/09674845.2012.12069133

de Boer IH, Astor BC, Kramer H, Palmas W, Rudser K, Seliger SL, et al. Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atheroslcerosis (MESA). Atherosclerosis. 2008;197(1):407–14. DOI: https://doi.org/10.1016/j.atherosclerosis.2007.06.018

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016 Jul 28 [cited 2019 Jul 2];375(4):311–22. DOI: https://doi.org/10.1056/NEJMoa1603827

Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017 [cited 2019 Jul 2];377(7):644–57. DOI: https://doi.org/10.1056/NEJMoa1611925

FDA approves Ozempic® for cardiovascular risk reduction in adults with type 2 diabetes and known heart disease, updates Rybelsus® label. [cited 2020 Jul 15]. Available from:

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet (London, England). 2019 [cited 2019 Jul 20];394(10193):121–30.

Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015 Nov 26 [cited 2019 Jul 2];373(22):2117–28. DOI: https://doi.org/10.1056/NEJMoa1504720

FDA Drug Safety Communication. FDA approves new treatment for a type of heart failure | FDA. 2020 [cited 2020 Jul 15].

McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995–2008. DOI: https://doi.org/10.1056/NEJMoa1911303

Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A. Glucagon-like peptide analogues for type 2 diabetes mellitus. Cochrane database Syst Rev. 2011 Oct 5 [cited 2019 Jun 26];(10):CD006423. DOI: https://doi.org/10.1002/14651858.CD006423.pub2

Arnold S V, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Mues KE, et al. Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease. Circulation. 2019 Aug 13 [cited 2020 mar 31];140(7):618–20. DOI: https://doi.org/10.1161/CIRCULATIONAHA.119.041730

Saxon DR, Reiter-Brennan C, Blaha MJ, Eckel RH. Cardiometabolic medicine: development of a new subspecialty. J Clin Endocrinol Metab. 2020;105(7):dgaa261 DOI: https://doi.org/10.1210/clinem/dgaa261

Eden J, Berwick D, Wilensky G. Graduate medical education that meets the nation’s health needs. Graduate Medical Education That Meets the Nation’s Health Needs 2014.

Fan W, Song Y, Inzucchi SE, Sperling L, Cannon CP, Arnold S V., et al. Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: the Diabetes Collaborative Registry. Diabetes, Obes Metab. 2019 May 14 [cited 2020 Aug 16];21(5):1121–7. DOI: https://doi.org/10.1111/dom.13625

Miele L, Targher G. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications. Vol. 9, Expert Review of Gastroenterology and Hepatology. Taylor and Francis Ltd; 2015 [cited 2020 Aug 30]. p. 1243–5. DOI: https://doi.org/10.1586/17474124.2015.1074860

Andreatta P, Marzano D. Healthcare management strategies. Curr Opin Obstet Gynecol. 2012 [cited 2020 Aug 12];24(6):445–52. DOI: https://doi.org/10.1097/GCO.0b013e328359f007

Fradgley EA, Paul CL, Bryant J. A systematic review of barriers to optimal outpatient specialist services for individuals with prevalent chronic diseases: what are the unique and common barriers experienced by patients in high income countries? Int J Equity Health. 2015 [cited 2020 Aug 12];14(1):52. DOI: https://doi.org/10.1186/s12939-015-0179-6

choen C, Osborn R, How SKH, Doty MM, Peugh J. In chronic condition: experiences of patients with complex health care needs, in eight countries, 2008. Health Aff. 2009;28(1). DOI: https://doi.org/10.1377/hlthaff.28.1.w1

Potthoff SA, Vonend O. Multidisciplinary approach in the treatment of resistant hypertension. Curr Hypertens Rep. 2017;19(1):9. DOI: https://doi.org/10.1007/s11906-017-0698-1

Virani SS, Akeroyd JM, Ramsey DJ, Chan WJ, Frazier L, Nasir K, et al. Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: implications for care under the Affordable Care Act. Am Heart J. 2016;181:74–82. DOI: https://doi.org/10.1016/j.ahj.2016.07.020

Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual Causes of Death in the United States, 2000. J Am Med Assoc. American Medical Association. 2004;291:1238–45. DOI: https://doi.org/10.1001/jama.291.10.1238

Lobelo F, Duperly J, Frank E. Physical activity habits of doctors and medical students influence their counselling practices. Br J Sports Med. 2009;43(2):89–92. DOI: https://doi.org/10.1136/bjsm.2008.055426

Eckel RH. Preventive cardiology by lifestyle intervention: Opportunity and/or challenge? Presidential address at the 2005 American Heart Association scientific sessions. In: Circulation. Circulation; 2006 [cited 2020 Aug 31]. p. 2657–61. DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.175744

Merz CNB, Alberts MJ, Balady GJ, Ballantyne CM, Berra K, Black HR, et al. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence And Training (writing committee to develop a competence and training statement on prevention of cardiovascular disease). Vol. 120, Circulation. 2009. DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.192640

Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med. 2014;31(7):764–72. DOI: https://doi.org/10.1111/dme.12428

Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882–887.e1. DOI: https://doi.org/10.1016/j.amjmed.2011.12.013

McEwen A, West R, McRobbie H. Effectiveness of specialist group treatment for smoking cessation vs. one-to-one treatment in primary care. Addict Behav. 2006 [cited 2020 Aug 13];31(9):1650–60. DOI: https://doi.org/10.1016/j.addbeh.2005.12.014

Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146. DOI: https://doi.org/10.1002/14651858.CD000146.pub4

Odphp. 2015–2020 Dietary guidelines for Americans. 2015 [cited 2020 Aug 13]. Available from: http://health.gov/dietaryguidelines/2015/guidelines/.

Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;378(25):e34. DOI: https://doi.org/10.1056/NEJMoa1800389

Eckel RH, Jakicic JM, Ard JD, De Jesus JM, Houston Miller N, Hubbard VS, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63(25 PART B):2960–84. DOI: https://doi.org/10.1161/01.cir.0000437740.48606.d1

American Diabetes Association. Standards of medical care in diabetes—2020. Care Diabetes J. 2020.

Franz MJ, MacLeod J, Evert A, Brown C, Gradwell E, Handu D, et al. Academy of nutrition and dietetics nutrition practice guideline for type 1 and type 2 diabetes in adults: systematic review of evidence for medical nutrition therapy effectiveness and recommendations for integration into the nutrition care process. J Acad Nutr Diet. 2017;117(10):1659–79. DOI: https://doi.org/10.1016/j.jand.2017.03.022

Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes. A meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25(7):1159–71. DOI: https://doi.org/10.2337/diacare.25.7.1159

He X, Li J, Wang B, Yao Q, Li L, Song R, et al. Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis. Endocrine. 2017;55(3):712–31. DOI: https://doi.org/10.1007/s12020-016-1168-2

Cooke D, Bond R, Lawton J, Rankin D, Heller S, Clark M, et al. Structured type 1 diabetes education delivered within routine care: impact on glycemic control and diabetes-specific quality of life. Diabetes Care. 2013;36(2):270–2. DOI: https://doi.org/10.2337/dc12-0080

Strawbridge LM, Lloyd JT, Meadow A, Riley GF, Howell BL. Use of Medicare’s diabetes self-management training benefit. Health Educ Behav. 2015;42(4):530–8. DOI: https://doi.org/10.1177/1090198114566271

Li R, Shrestha SS, Lipman R, Burrows NR, Kolb LE, Rutledge S, et al. Diabetes self-management education and training among privately insured persons with newly diagnosed diabetes--United States, 2011-2012. MMWR Morb Mortal Wkly Rep. 2014;63(46):1045–9.

Suaya JA, Shepard DS, Normand SLT, Ades PA, Prottas J, Stason WB. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation. 2007;116(15):1653–62. DOI: https://doi.org/10.1161/CIRCULATIONAHA.107.701466

Polgreen LA, Han J, Carter BL, Ardery GP, Coffey CS, Chrischilles EA, et al. Cost-effectiveness of a physician-pharmacist collaboration intervention to improve blood pressure control. Hypertension. 2015 [cited 2020 Aug 31];66(6):1145–51. Available from: https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.115.06023 DOI: https://doi.org/10.1161/HYPERTENSIONAHA.115.06023

Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. American Medical Association; 2009 [cited 2020 Aug 31];169:1748–55. Available from: https://jamanetwork.com/ DOI: https://doi.org/10.1001/archinternmed.2009.316

Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–35. DOI: https://doi.org/10.1161/CIRCULATIONAHA.108.768986

Warden BA, Shapiro MD, Fazio S. The role of the clinical pharmacist in a preventive cardiology practice. Ann Pharmacother. 2019 [cited 2020 Aug 31];53(12):1214–9. DOI: https://doi.org/10.1177/1060028019864669